TrialDiabetes, obesity & metabolism2022

Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trial.

Marcel H A Muskiet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.